您的位置: 首页 > 农业专利 > 详情页

NOUVEAU DÉRIVÉ DE QUINOLINONE ET COMPOSITION PHARMACEUTIQUE POUR PRÉVENIR OU TRAITER UNE MALADIE ALLERGIQUE TELLE QUE L'ASTHME OU L'ATOPIE COMPRENANT CELUI-CI EN TANT QUE PRINCIPE ACTIF
专利权人:
Korea University Research and Business Foundation; Sejong Campus
发明人:
BYUN, Youngjoo,JEON, Young Ho,LEE, Kiho,LEE, Ki Yong,JUNG, Yong Woo,SON, Sang-Hyun
申请号:
EP18736592
公开号:
EP3567044A4
申请日:
2018.01.04
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention relates to a novel quinolinone derivative compound that regulates intracellular signal transduction mediated by TSLP and IL-33 to exhibit efficacy in preventing or treating allergic diseases such as asthma or atopic dermatitis. The quinolinone derivative compound of the present invention can effectively suppress inflammatory responses of allergic diseases such as asthma or atopic dermatitis. The present invention also relates to a pharmaceutical composition including the quinolinone derivative compound. The pharmaceutical composition of the present invention can be used to fundamentally prevent or treat various allergic and asthmatic diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充